As of Feb 24
| +0.25 / +0.21%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 131.50, with a high estimate of 170.00 and a low estimate of 101.00. The median estimate represents a +12.26% increase from the last price of 117.14.
The current consensus among 10 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.